RazorMetrics Partners With West Virginia on Drug Costs

The Austin, Texas pharmacy technology company will provide its cost containment platform to Medicaid and PEIA programs covering roughly 540,000 members.

Updated on Nov. 17, 2026 in Healthcare

Bold flat-color editorial illustration of a stack of amber capsules beside an empty glass vial, with a forested ridgeline shape behind, evoking prescription cost containment.
RazorMetrics announced partnerships with West Virginia to deliver prescription cost savings for roughly 540,000 Medicaid and PEIA members without financial risk to the state. AI Illustration. Upload story photo >

Live Poll

Do you support state governments hiring private firms to cut prescription drug costs?

RazorMetrics, a pharmacy technology company based in Austin, Texas, announced new partnerships with West Virginia to reduce prescription drug costs for Medicaid and PEIA. The partnerships cover just under 400,000 Medicaid members and approximately 142,000 PEIA members.

Why it matters

The contracts are structured to deliver savings without financial risk to the state, and West Virginia's polypharmacy rates are among the highest in the nation. The effort targets avoidable prescription spending, such as duplicate therapies and unnecessary medication supply, that adds costs to health plans and public programs.

RazorMetrics reports more than $800 million in savings nationwide from its platform, but the announcement gives no West Virginia-specific savings target or contract value. The partnerships reach just under 400,000 Medicaid members and approximately 142,000 PEIA members.

The players

RazorMetrics

A pharmacy technology company based in Austin, Texas, which provides a pharmacy cost containment platform to health plans and public programs.

The details

The program uses RazorMetrics' platform to identify lower-cost medication alternatives, support deprescribing, and remove duplicate therapies within prescribers' existing workflows. The company says the platform operates through prescriber-driven decisions with full line-of-sight on a member's prescriptions.

Timeline

  1. November 17, 2026: RazorMetrics announces the West Virginia partnerships.

Market Landscape

The partnership extends the RazorMetrics pharmacy cost containment platform, which the company says has generated more than $800 million in savings nationwide, into state-run Medicaid and public employee programs. It positions a pharmacy technology vendor directly inside public payer prescription spending, a segment where cost-control tools compete for state contracts.

For West Virginia residents enrolled in Medicaid or PEIA, the partnerships may affect how prescriptions are reviewed and which medication alternatives prescribers consider. The announcement does not state whether member copays, coverage rules, or formularies will change.

The takeaway

Cost-control programs that work within prescriber decisions rather than restricting them may shape how states balance spending with access to clinically appropriate medications. Readers can watch for published savings results from the West Virginia partnerships to judge their effect.

Further reading

For related coverage, see Healthcare in the business section.

Source note: This article includes information reported by Star Local.

Live Poll

Do you support state governments hiring private firms to cut prescription drug costs?